Back
Kymera Therapeutics Stock Price Chart
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.
Buy
67
KYMR
Kymera Therapeutics
Last Price:
48.00
Seasonality Move:
69.6%
7 Day Trial
ALL ACCESS PASS
$
7
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.- The current trend is moderately bullish and KYMR is experiencing slight buying pressure.
Kymera Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.05 | Buy |
| 20-day SMA: | 45.95 | Buy |
| 50-day SMA: | 47 | Buy |
| 200-day SMA: | 39.47 | Buy |
| 8-day EMA: | 48.01 | Buy |
| 20-day EMA: | 47.14 | Buy |
| 50-day EMA: | 46 | Buy |
| 200-day EMA: | 39.23 | Buy |
Kymera Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.64 | Buy |
| Relative Strength Index (14 RSI): | 55.62 | Buy |
| Chaikin Money Flow: | 18998 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44 - 49.52) | Buy |
| Bollinger Bands (100): | (36.4 - 48.82) | Buy |
Kymera Therapeutics Technical Analysis
| Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Kymera Therapeutics Stock
Is Kymera Therapeutics Stock a Buy?
- Kymera Therapeutics share price is 48.49 while KYMR 8-day simple moving average is 48.05, which is a Buy signal.
- The stock price of KYMR is 48.49 while Kymera Therapeutics 20-day SMA is 45.95, which makes it a Buy.
- Kymera Therapeutics 50-day simple moving average is 47.00 while KYMR share price is 48.49, making it a Buy technically.
- KYMR stock price is 48.49 and Kymera Therapeutics 200-day simple moving average is 39.47, creating a Buy signal.
KYMR Technical Analysis vs Fundamental Analysis
Buy
67
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy or a Sell?
-
Kymera Therapeutics stock is rated a Buy
The current Kymera Therapeutics [KYMR] share price is $48.49. The Score for KYMR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
Kymera Therapeutics Stock Info
Market Cap:
2.99B
Price in USD:
48.49
Share Volume:
355.89K
Kymera Therapeutics 52-Week Range
52-Week High:
53.27
52-Week Low:
9.60
Buy
67
Kymera Therapeutics (KYMR)
is a Buy
Kymera Therapeutics Share Price Forecast
-
What is the Kymera Therapeutics stock price today?
The Kymera Therapeutics stock price is 48.49 USD today. -
Will KYMR stock go up or go down?
Kymera Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Kymera Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Kymera Therapeutics is not overvalued.
Is Kymera Therapeutics Stock a Buy?
- Kymera Therapeutics share price is 48.49 while KYMR 8-day exponential moving average is 48.01, which is a Buy signal.
- The stock price of KYMR is 48.49 while Kymera Therapeutics 20-day EMA is 47.14, which makes it a Buy.
- Kymera Therapeutics 50-day exponential moving average is 46.00 while KYMR share price is 48.49, making it a Buy technically.
- KYMR stock price is 48.49 and Kymera Therapeutics 200-day simple moving average is 39.23, creating a Buy signal.
Fundamental Analysis of Kymera Therapeutics
Is Kymera Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.
Technical Analysis of Kymera Therapeutics
Should I short Kymera Therapeutics stock?
- KYMR Moving Average Covergence Divergence (MACD) indicator is 0.64, suggesting Kymera Therapeutics is a Buy
- Kymera Therapeutics Relative Strength Index (RSI) is 55.62, which suggest Kymera Therapeutics is overbought
- The Bollinger Bands (25) for Kymera Therapeutics is (44 - 49.52), which suggest Kymera Therapeutics is a Buy
- The Bollinger Bands (100) for Kymera Therapeutics is (36.4 - 48.82), which suggest Kymera Therapeutics is a Buy
* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.